Patents by Inventor Eric Guenzi

Eric Guenzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases
    Publication number: 20100034749
    Abstract: The present invention relates to cationic colloidal preparations and their use for the diagnosis and/or treatment of ocular diseases.
    Type: Application
    Filed: July 9, 2007
    Publication date: February 11, 2010
    Applicants: MediGene AG, Universitatsklinikum Freiburg
    Inventors: Brita Schulze, Uwe Michaella, Hansjürgen Agostini, Jing Hua, Eric Guenzi, Gottfried Martin, Lutz Hansen
  • Cationic Liposomal Preparations for the Treatment of Rheumatoid Arthritis
    Publication number: 20090232731
    Abstract: The present invention refers to the use of cationic liposomal preparations for the treatment or diagnosis of rheumatoid arthritis or related disorders.
    Type: Application
    Filed: May 18, 2007
    Publication date: September 17, 2009
    Inventors: Martin Funk, Brita Schulze, Eric Guenzi, Uwe Michaelis, Hermann Bohnenkamp, Martin Eichhorn, Marcus Schmitt-Sody
  • Elisa method for the detection of guanylate binding protein 1 (gbp-1)
    Patent number: 7498144
    Abstract: A method for the identification and/or quantification of GBP-1 or fragments of this protein in the culture supernatant of a tissue sample, a body fluid sample or a sample from a cell culture supernatant is described.
    Type: Grant
    Filed: December 19, 2003
    Date of Patent: March 3, 2009
    Assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Gesundheit und Umwelt (GmbH)
    Inventors: Michael Stürzl, Clara Lubeseder-Martellato, Eric Guenzi, Elisabeth Kremmer
  • Elisa method for the detection of guanylate binding protein 1 (gbp-1)
    Publication number: 20060154316
    Abstract: A method for the identification and/or quantification of GBP-1 or fragments of this protein in the culture supernatant of a tissue sample, a body fluid sample or a sample from a cell culture supernatant is described.
    Type: Application
    Filed: December 19, 2003
    Publication date: July 13, 2006
    Applicant: GSF-Forschungszentrum für Umwelt und Gesundheit GmbH
    Inventors: Michael Sturzl, Clara Lubeseder-Martellato, Eric Guenzi, Elisabeth Kremmer